Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know

Zacks
Apri Zacks
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know

Intuitive Surgical, Inc. (ISRG) closed at $406.78 in the latest trading session, marking a -1.16% move from the prior day. This change lagged the S&P 500's daily gain of 0.42%. At the same time, the Dow added 0.29%, and the tech-heavy Nasdaq gained 0.29%.

Prior to today's trading, shares of the company had lost 0.33% lagged the Medical sector's gain of 5.6% and the S&P 500's gain of 2.2%.

The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company is expected to report EPS of $2.48, up 13.24% from the prior-year quarter. Alongside, our most recent consensus estimate is anticipating revenue of $2.81 billion, indicating a 15% upward movement from the same quarter last year.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $10.41 per share and a revenue of $11.72 billion, indicating changes of +16.57% and +16.47%, respectively, from the former year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Intuitive Surgical, Inc. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #2 (Buy).

From a valuation perspective, Intuitive Surgical, Inc. is currently exchanging hands at a Forward P/E ratio of 39.54. Its industry sports an average Forward P/E of 25.9, so one might conclude that Intuitive Surgical, Inc. is trading at a premium comparatively.

We can also see that ISRG currently has a PEG ratio of 2.76. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. ISRG's industry had an average PEG ratio of 2.24 as of yesterday's close.

The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 153, which puts it in the bottom 38% of all 250+ industries.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow ISRG in the coming trading sessions, be sure to utilize Zacks.com.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Intuitive Surgical, Inc. (ISRG): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research